SK719789A3 - Xantine derivatives, method for producing thereof, pharmaceutical composition containing them and their use - Google Patents
Xantine derivatives, method for producing thereof, pharmaceutical composition containing them and their use Download PDFInfo
- Publication number
- SK719789A3 SK719789A3 SK7197-89A SK719789A SK719789A3 SK 719789 A3 SK719789 A3 SK 719789A3 SK 719789 A SK719789 A SK 719789A SK 719789 A3 SK719789 A3 SK 719789A3
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- formula
- substd
- opt
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3843117A DE3843117A1 (de) | 1988-12-22 | 1988-12-22 | Neue xanthinderivate mit adenosin-antagonistischer wirkung |
Publications (2)
Publication Number | Publication Date |
---|---|
SK719789A3 true SK719789A3 (en) | 1998-12-02 |
SK279525B6 SK279525B6 (sk) | 1998-12-02 |
Family
ID=6369764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK7197-89A SK279525B6 (sk) | 1988-12-22 | 1989-12-19 | Xantínové deriváty, spôsob ich výroby, farmaceutic |
Country Status (32)
Country | Link |
---|---|
US (4) | US5175291A (hu) |
EP (1) | EP0374808B1 (hu) |
JP (1) | JP2565576B2 (hu) |
KR (1) | KR0165666B1 (hu) |
AT (1) | ATE136897T1 (hu) |
BG (1) | BG61669B2 (hu) |
BR (1) | BR1100527A (hu) |
CA (1) | CA2006387C (hu) |
CZ (1) | CZ286230B6 (hu) |
DD (1) | DD290421A5 (hu) |
DE (3) | DE8817122U1 (hu) |
DK (1) | DK652689A (hu) |
ES (1) | ES2086313T3 (hu) |
FI (1) | FI96513C (hu) |
GR (1) | GR3019733T3 (hu) |
HR (1) | HRP940724A2 (hu) |
HU (1) | HU218674B (hu) |
IE (1) | IE74205B1 (hu) |
IL (1) | IL92829A (hu) |
MX (1) | MX9203618A (hu) |
NO (1) | NO173502C (hu) |
NZ (1) | NZ231901A (hu) |
PH (2) | PH31107A (hu) |
PL (1) | PL162877B1 (hu) |
PT (1) | PT92658B (hu) |
RU (1) | RU2057752C1 (hu) |
SG (1) | SG46380A1 (hu) |
SI (1) | SI8912423B (hu) |
SK (1) | SK279525B6 (hu) |
UA (1) | UA26427A (hu) |
YU (1) | YU47934B (hu) |
ZA (1) | ZA899881B (hu) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE8817122U1 (de) * | 1988-12-22 | 1993-02-04 | Boehringer Ingelheim Kg, 55218 Ingelheim | Neue Xanthinderivate mit Adenosinantogenistischer Wirkung |
US5290782A (en) * | 1989-09-01 | 1994-03-01 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
JPH06102662B2 (ja) * | 1989-09-01 | 1994-12-14 | 協和醗酵工業株式会社 | キサンチン誘導体 |
US5047534A (en) * | 1990-03-26 | 1991-09-10 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine receptor agents |
DE4019892A1 (de) * | 1990-06-22 | 1992-01-02 | Boehringer Ingelheim Kg | Neue xanthinderivate |
CA2061544A1 (en) * | 1991-02-25 | 1992-08-26 | Fumio Suzuki | Xanthine compounds |
GB9111131D0 (en) * | 1991-05-23 | 1991-07-17 | Ici Plc | Heterocyclic compounds |
GB9111130D0 (en) * | 1991-05-23 | 1991-07-17 | Ici Plc | Azole derivatives |
EP0541120B1 (en) * | 1991-11-08 | 1999-05-26 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives for the treatment of dementia |
IT1260444B (it) * | 1992-01-24 | 1996-04-09 | Mario Brufani | Derivati della 8-(1-amminocicloalchil)1,3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti |
EP0556778A3 (en) * | 1992-02-17 | 1993-11-24 | Kyowa Hakko Kogyo Kk | Xanthine derivatives |
CA2093403C (en) * | 1992-04-08 | 1999-08-10 | Fumio Suzuki | Therapeutic agent for parkinson's disease |
US5484920A (en) * | 1992-04-08 | 1996-01-16 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for Parkinson's disease |
WO1994003173A1 (de) * | 1992-08-01 | 1994-02-17 | Boehringer Ingelheim Kg | Verwendung von 8-(3-oxocyclopentyl)-1,3-dipropyl-7h-purin-2,6-dion zur symptomatischen behandlung der zystischen fibrose |
TW252044B (hu) * | 1992-08-10 | 1995-07-21 | Boehringer Ingelheim Kg | |
US5288721A (en) * | 1992-09-22 | 1994-02-22 | Cell Therapeutics, Inc. | Substituted epoxyalkyl xanthines |
JP2613355B2 (ja) * | 1992-09-28 | 1997-05-28 | 協和醗酵工業株式会社 | パーキンソン氏病治療剤 |
US5877179A (en) * | 1992-09-29 | 1999-03-02 | The United States Of America As Represented By The Department Of Health And Human Services | Xanthines for identifying CFTR--binding compounds useful for activating chloride conductance in animal cells |
DE4236331A1 (de) * | 1992-10-28 | 1994-05-05 | Boehringer Ingelheim Kg | Synergistische Kombination |
WO1994015605A1 (en) * | 1993-01-14 | 1994-07-21 | Cell Therapeutics, Inc. | Acetal or ketal substituted therapeutic compounds |
JPH08512281A (ja) * | 1993-02-26 | 1996-12-24 | メレル ダウ ファーマス−ティカルズ インコーポレイテッド | アデノシンa▲下1▼受容体拮抗剤としてのキサンチン誘導体類 |
AU6781194A (en) * | 1993-05-03 | 1994-11-21 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists |
DE4316576A1 (de) * | 1993-05-18 | 1994-11-24 | Boehringer Ingelheim Kg | Verbessertes Verfahren zur Herstellung von 1,3-Dipropyl-8-(3-Oxocyclopentyl)-xanthin |
US5446046A (en) * | 1993-10-28 | 1995-08-29 | University Of Florida Research Foundation | A1 adenosine receptor agonists and antagonists as diuretics |
US5736528A (en) * | 1993-10-28 | 1998-04-07 | University Of Florida Research Foundation, Inc. | N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists |
JP3769737B2 (ja) * | 1994-03-30 | 2006-04-26 | 味の素株式会社 | シクロプロパン誘導体及びその製造法 |
US5591776A (en) * | 1994-06-24 | 1997-01-07 | Euro-Celtique, S.A. | Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
JP2001523213A (ja) * | 1994-12-13 | 2001-11-20 | ユーロ−セルティーク,エス.エイ. | 三置換チオキサンチン類 |
US6066641A (en) * | 1994-12-13 | 2000-05-23 | Euro-Celtique S.A. | Aryl thioxanthines |
US5864037A (en) * | 1996-06-06 | 1999-01-26 | Euro-Celtique, S.A. | Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity |
US5789416B1 (en) * | 1996-08-27 | 1999-10-05 | Cv Therapeutics Inc | N6 mono heterocyclic substituted adenosine derivatives |
US5786360A (en) * | 1996-11-19 | 1998-07-28 | Link Technology Incorporated | A1 adenosine receptor antagonists |
US6727259B2 (en) * | 1997-09-05 | 2004-04-27 | Kyowa Hakko Kogyo Co., Ltd. | Remedial agent for neural degeneration |
US6248746B1 (en) | 1998-01-07 | 2001-06-19 | Euro-Celtique S.A. | 3-(arylalkyl) xanthines |
DE19816857A1 (de) * | 1998-04-16 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue unsymmetrisch substituierte Xanthin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
ATE342734T1 (de) * | 1998-06-01 | 2006-11-15 | Astellas Pharma Inc | Adenosin a1 antagonisten gegen männliche sterilität |
AU4980999A (en) | 1998-07-10 | 2000-02-01 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | A3 adenosine receptor antagonists |
US6025362A (en) * | 1998-08-31 | 2000-02-15 | Fukunaga; Atsuo F. | Uses of xanthine compounds |
US6576619B2 (en) | 1999-05-24 | 2003-06-10 | Cv Therapeutics, Inc. | Orally active A1 adenosine receptor agonists |
US6545002B1 (en) * | 1999-06-01 | 2003-04-08 | University Of Virginia Patent Foundation | Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors |
EA005211B1 (ru) * | 1999-11-12 | 2004-12-30 | Байоджен, Инк. | Полициклоалкилпурины в качестве антагонистов аденозиновых рецепторов |
NZ519427A (en) * | 1999-11-12 | 2003-08-29 | Biogen Inc | Polycycloalkylpurine derivative useful as an adenosine receptor antagonist |
DE60122285D1 (de) | 2000-01-14 | 2006-09-28 | Us Gov Health & Human Serv | Methonocarbacycloalkylanaloga von nucleosiden |
US20020115635A1 (en) * | 2001-02-21 | 2002-08-22 | Pnina Fishman | Modulation of GSK-3beta activity and its different uses |
IL161867A0 (en) | 2001-11-09 | 2005-11-20 | Cv Therapeutics Inc | A2b adenosine receptor antagonists |
US7125993B2 (en) * | 2001-11-09 | 2006-10-24 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
US7317017B2 (en) * | 2002-11-08 | 2008-01-08 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
US6977300B2 (en) * | 2001-11-09 | 2005-12-20 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
US20080318983A1 (en) * | 2001-11-09 | 2008-12-25 | Rao Kalla | A2b adenosine receptor antagonists |
US20040106797A1 (en) * | 2002-07-19 | 2004-06-03 | Pascal Druzgala | Novel xanthines having adenosine A1-receptor antagonist properties |
WO2004074247A2 (en) * | 2003-02-19 | 2004-09-02 | Endacea, Inc. | A1 adenosine receptor antagonists |
US20040229901A1 (en) * | 2003-02-24 | 2004-11-18 | Lauren Otsuki | Method of treatment of disease using an adenosine A1 receptor antagonist |
NZ543109A (en) * | 2003-04-25 | 2008-06-30 | Novacardia Inc | Method of improved diuresis in individuals with impaired renal function |
US20060293312A1 (en) * | 2003-04-25 | 2006-12-28 | Howard Dittrich | Method of improved diuresis in individuals with impaired renal function |
MXPA05011860A (es) * | 2003-05-06 | 2006-02-17 | Cv Therapeutics Inc | Derivados de xantina como antagonistas del receptor de adenosina a2b. |
WO2005009343A2 (en) * | 2003-06-06 | 2005-02-03 | Endacea, Inc. | A1 adenosine receptor antogonists |
US20090068101A9 (en) * | 2003-06-09 | 2009-03-12 | Endacea, Inc. | A1 Adenosine Receptor Antagonists |
TW200507882A (en) * | 2003-07-17 | 2005-03-01 | Kyowa Hakko Kogyo Kk | Solid formulations |
US6847249B1 (en) * | 2003-10-09 | 2005-01-25 | Analog Devices, Inc. | Highest available voltage selector circuit |
BRPI0509753A (pt) * | 2004-04-16 | 2007-10-16 | Novacardia Inc | composição farmacêutica e método de tratamento de doença cardiovascular |
RU2385322C2 (ru) * | 2004-09-01 | 2010-03-27 | Си Ви Терапьютикс, Инк. | Способ заживления ран с применением антагонистов аденозинового рецептора a2b |
CN101466383A (zh) * | 2006-06-16 | 2009-06-24 | 美国诺华卡迪亚公司 | 包含低频率投与aa1ra的肾功能延长改善 |
US8193200B2 (en) | 2007-01-04 | 2012-06-05 | University Of Virginia Patent Foundation | Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease |
US20080242684A1 (en) * | 2007-03-29 | 2008-10-02 | Howard Dittrich | Methods of administration of adenosine a1 receptor antagonists |
WO2008121893A1 (en) * | 2007-03-29 | 2008-10-09 | Novacardia, Inc. | Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist |
EP2268641B1 (en) * | 2008-03-26 | 2014-09-03 | Advinus Therapeutics Pvt. Ltd. | Heterocyclic compounds as adenosine receptor antagonist |
US8129862B2 (en) * | 2009-10-23 | 2012-03-06 | Analog Devices, Inc. | Scalable highest available voltage selector circuit |
WO2011055391A1 (en) * | 2009-11-09 | 2011-05-12 | Advinus Therapeutics Private Limited | Substituted fused pyrimidine compounds, its preparation and uses thereof |
US8518957B2 (en) | 2009-12-02 | 2013-08-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1201997A (en) * | 1967-08-04 | 1970-08-12 | Yissum Res Dev Co | New substituted purines and purine derivatives |
US3624215A (en) * | 1970-06-25 | 1971-11-30 | Abbott Lab | 8-substituted theophyllines as anti-anxiety agents |
US3624216A (en) * | 1970-06-25 | 1971-11-30 | Abbott Lab | 8-substituted theophyllines as anti-inflammatory agents |
DE3028273A1 (de) * | 1980-07-25 | 1982-02-25 | Fa. Dr. Willmar Schwabe, 7500 Karlsruhe | Durch purinbasen substituierte 1.4;3.6-dianhydro-hexit-nitrate |
ES8401072A1 (es) * | 1982-11-23 | 1983-12-16 | Faes | Procedimiento de preparacion de un nuevo espirodecano. |
US4593095A (en) * | 1983-02-18 | 1986-06-03 | The Johns Hopkins University | Xanthine derivatives |
US4548939A (en) * | 1984-10-01 | 1985-10-22 | Janssen Pharmaceutica N. V. | 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones |
US4755517A (en) * | 1986-07-31 | 1988-07-05 | Warner-Lambert Company | Derivatives of xanthine, pharmaceutical compositions and methods of use therefor |
US5175290A (en) * | 1988-09-16 | 1992-12-29 | Marion Merrell Dow Inc. | 8-(oxo-substituted cycloalkyl)xanthines |
DE8817122U1 (de) * | 1988-12-22 | 1993-02-04 | Boehringer Ingelheim Kg, 55218 Ingelheim | Neue Xanthinderivate mit Adenosinantogenistischer Wirkung |
US5290782A (en) * | 1989-09-01 | 1994-03-01 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
JPH06102662B2 (ja) * | 1989-09-01 | 1994-12-14 | 協和醗酵工業株式会社 | キサンチン誘導体 |
US4957921A (en) * | 1989-12-06 | 1990-09-18 | Warner-Lambert Company | Substituted cyclohexanols as central nervous system agents |
EP0541120B1 (en) * | 1991-11-08 | 1999-05-26 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives for the treatment of dementia |
-
1988
- 1988-12-22 DE DE8817122U patent/DE8817122U1/de not_active Expired - Lifetime
- 1988-12-22 DE DE3843117A patent/DE3843117A1/de not_active Ceased
-
1989
- 1989-12-19 CZ CS19897197A patent/CZ286230B6/cs not_active IP Right Cessation
- 1989-12-19 AT AT89123412T patent/ATE136897T1/de not_active IP Right Cessation
- 1989-12-19 DE DE58909657T patent/DE58909657D1/de not_active Expired - Fee Related
- 1989-12-19 EP EP89123412A patent/EP0374808B1/de not_active Expired - Lifetime
- 1989-12-19 SK SK7197-89A patent/SK279525B6/sk unknown
- 1989-12-19 ES ES89123412T patent/ES2086313T3/es not_active Expired - Lifetime
- 1989-12-19 SG SG1996003965A patent/SG46380A1/en unknown
- 1989-12-20 SI SI8912423A patent/SI8912423B/sl unknown
- 1989-12-20 YU YU242389A patent/YU47934B/sh unknown
- 1989-12-20 PL PL28287889A patent/PL162877B1/pl unknown
- 1989-12-20 NZ NZ231901A patent/NZ231901A/en unknown
- 1989-12-20 FI FI896117A patent/FI96513C/fi not_active IP Right Cessation
- 1989-12-20 DD DD89335983A patent/DD290421A5/de not_active IP Right Cessation
- 1989-12-21 NO NO895168A patent/NO173502C/no not_active IP Right Cessation
- 1989-12-21 UA UA5011448A patent/UA26427A/uk unknown
- 1989-12-21 HU HU736/89A patent/HU218674B/hu not_active IP Right Cessation
- 1989-12-21 CA CA002006387A patent/CA2006387C/en not_active Expired - Fee Related
- 1989-12-21 KR KR1019890019085A patent/KR0165666B1/ko not_active IP Right Cessation
- 1989-12-21 PH PH39764A patent/PH31107A/en unknown
- 1989-12-21 DK DK652689A patent/DK652689A/da not_active Application Discontinuation
- 1989-12-21 IE IE414789A patent/IE74205B1/en not_active IP Right Cessation
- 1989-12-21 ZA ZA899881A patent/ZA899881B/xx unknown
- 1989-12-21 PT PT92658A patent/PT92658B/pt not_active IP Right Cessation
- 1989-12-21 IL IL9282989A patent/IL92829A/en active IP Right Grant
- 1989-12-22 JP JP1334668A patent/JP2565576B2/ja not_active Expired - Lifetime
-
1991
- 1991-04-25 US US07/691,193 patent/US5175291A/en not_active Expired - Fee Related
-
1992
- 1992-05-07 RU SU925011448A patent/RU2057752C1/ru active
- 1992-06-26 MX MX9203618A patent/MX9203618A/es unknown
- 1992-07-10 PH PH44630A patent/PH31111A/en unknown
-
1993
- 1993-07-27 US US08/097,478 patent/US5532368A/en not_active Expired - Fee Related
-
1994
- 1994-02-08 BG BG098441A patent/BG61669B2/bg unknown
- 1994-10-21 HR HRP-2423/89A patent/HRP940724A2/hr not_active Application Discontinuation
-
1995
- 1995-05-30 US US08/454,452 patent/US5696124A/en not_active Expired - Fee Related
-
1996
- 1996-04-23 GR GR960401119T patent/GR3019733T3/el unknown
- 1996-06-14 US US08/663,417 patent/US5688802A/en not_active Expired - Fee Related
-
1997
- 1997-05-13 BR BR1100527-0A patent/BR1100527A/pt active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK719789A3 (en) | Xantine derivatives, method for producing thereof, pharmaceutical composition containing them and their use | |
US5641784A (en) | 8-substituted 1,3-dialiphaticxanthine derivatives | |
US4201860A (en) | Purine derivatives | |
EP0759921B1 (en) | Process for the preparation of azabicyclic derivatives | |
US4172829A (en) | 2,9-Disubstituted adenine derivatives and their use as non-adrenergic bronchodilators | |
CA1252086A (en) | Pyrazole derivatives with an ergoline skeleton, their acid addition salts, and a process for the preparation thereof | |
US4381305A (en) | Ethylenediamine derivatives and pharmaceutical compositions containing same | |
CA1254208A (en) | 3,7-diazabicyclo¬3.3.1|nonanes and preparation thereof | |
US4232155A (en) | Purine compounds | |
US4826975A (en) | Fused cycloaliphatic aminoalcohols | |
JPS6072879A (ja) | 7−オキサビシクロヘプタン置換チオカルバメ−トプロスタグランジン類縁体 | |
JPH02289581A (ja) | 光学的に純粋なヘトラゼピン類の改良された製造方法 | |
US4410526A (en) | Oxazolidin-2-one prostaglandin compounds | |
JPH0530835B2 (hu) | ||
US4269839A (en) | Alkylthio-adenines used as bronchodilators | |
JPS6229568A (ja) | メチル−9−オキソ−11α,16−ジヒドロキシ−16−ビニル−5−シス−13−トランス−プロスタジエノエ−ト類の前駆物質及び合成法 | |
US2792413A (en) | Resolution of 7-carboethoxy-3-acetylthioheptanoic acid | |
DK145906B (da) | Analogifremgangsmaade til fremstilling af n,n-dimethyl-trans-2-(m-halogenphenyl)bicyclo(2,2,2)oct-3-yl-methylamin og syreadditionssalte deraf | |
FR2463142A1 (fr) | Nouveaux composes de purine, leur procede de production et composition pharmaceutique les contenant | |
NO122834B (hu) |